Results 151 to 160 of about 131,822 (267)

Dihydroxy fatty acids can be used for screening autism traits in toddlers

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Takaharu Hirai, Naoko Umeda, Takayo Ohto‐Nakanishi, Toru Fujioka, Keisuke Wakusawa, Takahiro Nara, Kenji J. Tsuchiya, Hideo Matsuzaki   +7 more
wiley   +1 more source

MELAS‐Like Mitochondrial Encephalopathy With Catatonia Associated With a Pathogenic MT‐ND3 (m.10158 T > C) Mutation: A Case Report and Literature Review

Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
Abstract Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke‐like episodes (MELAS) is a rare multisystem mitochondrial disorder primarily caused by mutations in mitochondrial DNA. While it typically presents with stroke‐like episodes, seizures, and lactic acidosis, recent evidence highlights a broader clinical spectrum, including ...
Faezeh Khorshidian, Vajiheh Aghamollaii, Mohammadreza Mousavipour, Setareh Rassa   +3 more
wiley   +1 more source

Emotional Intelligence and Its Influence on Internet Addiction and Eating Disorders: A Quantitative Approach

Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
ABSTRACT Emotional intelligence (EI) has emerged as a critical determinant of psychological well‐being, influencing individuals' capacity to manage stress, navigate social challenges, and regulate emotions. However, its role in shaping vulnerability to behavioral disorders—particularly eating disorders (ED) and Internet addiction (IA)—remains complex ...
Faezeh Khorshidian, Angela Hamidia, Farzan Kheirkhah, Davood Hosseini Talari, Ali Bijani, Mahbobeh Faramarzi, Seyedeh Mahbobeh Mirtabar   +6 more
wiley   +1 more source

Breaking the Seizure Code: Challenges in Identifying and Managing Functional and Dissociative Seizures

Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
ABSTRACT Functional and dissociative seizures (FDS), formerly known as psychogenic non‐epileptic seizures (PNES), closely mimic epileptic seizures but are not caused by abnormal epileptiform activity in the cerebral cortex. This resemblance poses significant challenges for accurate diagnosis and effective management.
Faezeh Khorshidian
wiley   +1 more source

Disruptive Psychopharmacology

JAMA Psychiatry, 2019
Boris D, Heifets, Robert C, Malenka
openaire   +3 more sources

Isolated Hypoglossal Nerve Palsy as an Initial Presentation of Metastatic Breast Cancer in Pregnancy: A Case Report

Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
ABSTRACT Isolated hypoglossal nerve palsy is rare, with neoplastic causes representing the most common etiology. We present an unusual case of metastatic breast cancer presenting with isolated hypoglossal nerve palsy during pregnancy. A 36‐year‐old primigravida at 17 weeks of gestation was admitted with progressive immobility, worsening back pain, and ...
Nalini Kurri, Muhammad Ibrahim Memon, Shaguna Chandran, Adnan Agha   +3 more
wiley   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, Volume 153, Issue 5, Page 402-431, May 2026.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

Clinical predictors of stimulant efficacy in adults with ADHD. [PDF]

Ther Adv Psychopharmacol
DiSalvo M, Biederman J, O'Connor H, Iorini M, Green A, Woodworth KY, Wozniak J, Joshi G, Gabrieli J, Uchida M.   +9 more
europepmc   +1 more source

Reclaiming Pharmacovigilance: Bridging the Evidence-Practice Gap in Psychopharmacology. [PDF]

J Eval Clin Pract
De Las Cuevas C.
europepmc   +1 more source

Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol‐free and low‐alcohol products in higher risk groups

Addiction, Volume 121, Issue 5, Page 1036-1041, May 2026.
Abstract Alcohol‐free and low‐alcohol drinks (no/lo drinks) are now widely available and popular with consumers in high‐income countries; however, it is unclear whether clinicians and others working to prevent or treat severe alcohol‐related health problems should take a zero‐tolerance approach to these alcohol‐like products or encourage patients to ...
John Holmes, Christopher K. Oldroyd, Colin Drummond, Matt Field, Inge Kersbergen, Michael E. D. Allison   +5 more
wiley   +1 more source